Reduction of early graft loss after intraportal porcine islet transplantation in monkeys

Transplantation

Volumn 83, Issue 2, 2007, Pages 202-210

  Rood, Pleunie P M ^a,b,c   Bottino, Rita ^a   Balamurugan, A N ^a,b   Smetanka, Cindy ^b   Ayares, David ^d   Groth, Carl Gustav ^e   Murase, Noriko ^b   Cooper, David K C ^b   Trucco, Massimo ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d REVIVICOR INC   (United States)

^e KAROLINSKA INSTITUTE   (Sweden)

Author keywords

1,3 galactosyltransferase gene knockout; Cynomolgus monkey; Instant blood mediated inflammatory reaction; Pancreatic islets; Pig; Xenotransplantation

Indexed keywords

ACETYLSALICYLIC ACID; CD40 LIGAND MONOCLONAL ANTIBODY; CEFAZOLIN; CIMETIDINE; COBROTOXIN; COMPLEMENT; DEXTRAN SULFATE; DIPHENHYDRAMINE; FAMOTIDINE; GANCICLOVIR; HEPARIN; LEVOFLOXACIN; METHYLPREDNISOLONE; METOCLOPRAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTACYCLIN; RAPAMYCIN; RITUXIMAB; STREPTOZOCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; COMPLEMENT INHIBITION; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT FAILURE; GRAFT INFECTION; GRAFT REJECTION; GRAFT SURVIVAL; HYPOGLYCEMIA; INFECTION PREVENTION; INFLAMMATORY DISEASE; INSTANT BLOOD MEDIATED INFLAMMATORY REACTION; MALE; MONKEY; MULTIPLE CYCLE TREATMENT; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STREPTOZOCIN DIABETES; SWINE; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; XENOTRANSPLANTATION;

ANIMALS; ANTICOAGULANTS; BLOOD GLUCOSE; C-PEPTIDE; COMPLEMENT HEMOLYTIC ACTIVITY ASSAY; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; MACACA FASCICULARIS; MALE; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 33846568901     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250680.36942.c6     Document Type: Article

References (32)

1. Nath DS, Hering BJ. Islet cells replacement therapy. Clin Lab Med 2005; 25: 541.
2. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230.
3. Korsgren O, Nilsson B, Berne C, et al. Current status of clinical islet transplantation. Transplantation 2005; 79: 1289.
4. Hamelmann W, Gray DW, Cairns TD, et al. Immediate destruction of xenogeneic islets in a primate model. Transplantation 1994; 58: 1109.
5. Bennet W, Sundberg B, Lundgren T, et al. Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation 2000; 69: 711.
6. Moberg L, Johansson H, Lukinius A, et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation. Lancet 2002; 360: 2039.
7. Johansson H, Lukinius A, Moberg L, et al. Tissue factor produced by the endocrine cells of the islets of Langerhans is associated with a negative outcome of clinical islet transplantation. Diabetes 2005; 54: 1755.
8. Mirenda V, Le Mauff B, Boeffard F, et al. Intact pancreatic islet function despite humoral xenorecognition in the pig-to-monkey combination. Transplantation 1998; 66: 1485.
9. Hering BJ, Wijkstrom M, Graham ML, et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates. Nat Med 2006; 12: 301.
10. Cardona K, Korbutt GS, Milas Z, et al. Long-term survival of neonatal porcine islets in nonhuman primates by targeting costimulation pathways. Nat Med 2006; 12: 304.
11. Banz Y, Cung T, Korchagina EY, Bovin NV, Haeberli A, Rieben R. Endothelial cell protection and complement inhibition in xenotransplantation: a novel in vitro model using whole blood. Xenotransplantation 2005; 12: 434.
12. Johansson H, Goto M, Siegbahn A, Elgue G, Korsgren O, Nilsson B. Low molecular weight dextran sulfate: a strong candidate drug to block IBMIR in clinical islet transplantation. Am J Transplant 2006; 6: 305.
13. Laumonier T, Walpen AJ, Maurus CF, et al. Dextran sulfate acts as an endothelial cell protectant and inhibits human complement and natural killer cell-mediated cytotoxicity against porcine cells. Transplantation 2003; 76: 838.
14. Phelps CJ, Koike C, Vaught TD, et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299: 411.
15. Bottino R, Balamurugan AN, Smetanka C, et al. Isolation outcome and functional characteristics of young and adult pig pancreatic islets for transplantation studies. Xenotransplantation (in press).
16. Dufrane D, Goebbels RM, Fdilat I, Guiot Y, Gianello P. Impact of porcine islet size on cellular structure and engraftment after transplantation: adult versus young pigs. Pancreas 2005; 30: 138.
17. Cooper DKC, Ye Y, Niekrasz M. Heart transplantation in primates. Experimental Techniques in Transplantation 1994; 177.
18. Rood PP, Smetanka C, Bottino R. Streptozotocin administration in young tethered monkeys - early response, dosage, and side effects. Xenotransplantation 2005; 12: 399.
19. Toso C, Brandhorst D, Oberholzer J, Triponez F, Buhler L, Morel P. Isolation of adult porcine islets of Langerhans. Cell Transplant 2000; 9: 297.
20. Yonekawa Y, Matsumoto S, Okitsu T, et al. Effective islet isolation method with extremely high islet yields from adult pigs. Cell Transplant 2005; 14: 757.
21. Balamurugan AN, Chang Y, Fung JJ, Trucco M, Bottino R. Flexible management of enzymatic digestion improves human islet isolation outcome from sub-optimal donor pancreata. Am J Transplant 2003; 3: 1135.
22. Bottino R, Balamurugan AN, Bertera S, Pietropaolo M, Trucco M, Piganelli JD. Preservation of human islet cell functional mass by antioxidative action of a novel SOD mimic compound. Diabetes 2002; 51: 2561.
23. Balamurugan AN, He J, Guo F, et al. Harmful delayed effects of exogenous isolation enzymes on isolated human islets: relevance to clinical transplantation. Am J Transplant 2005; 5: 2671.
24. Bottino R, Balamurugan AN, Tse H, et al. Response of human islets to isolation stress and the effect of antioxidant treatment. Diabetes 2004; 53: 2559.
25. Balamurugan AN, Chang Y, Bertera S, et al. Suitability of human juvenile pancreatic islets for clinical use. Diabetologia 2006; 49: 1845.
26. Bertera S, Crawford ML, Alexander AM, et al. Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 2003; 52: 387.
27. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994; 368: 756.
28. Knosalla C, Ryan DJ, Moran K, et al. Initial experience with the human anti-human CD154 monoclonal antibody, ABI793, in pig-to-baboon xenotransplantation. Xenotransplantation 2004; 11: 353.
29. Moberg L. The role of the innate immunity in islet transplantation. Ups J Med Sci 2005; 110: 17.
30. Steele C, Hagopian WA, Gitelman S, et al. Insulin secretion in type 1 diabetes. Diabetes 2004; 53: 426.
31. Gray DW. Avoiding damage to transplanted human islets during implantation is important. Transplantation 2005; 79: 1294.
32. Buhler L, Awwad M, Basker M, et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69: 2296.